Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-011086
Filing Date
2021-03-10
Accepted
2021-03-10 21:30:11
Documents
1
Period of Report
2021-03-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 28931
  Complete submission text file 0000899243-21-011086.txt   30817
Mailing Address PO BOX N7776 LYFORD BAHAMAS
Business Address
LEWIS JOSEPH (Reporting) CIK: 0001015747 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 21731601

Mailing Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-332-3410
Mirati Therapeutics, Inc. (Issuer) CIK: 0001576263 (see all company filings)

EIN.: 462693615 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address CAY HOUSE EP TAYLOR DRIVE N7776 LYFORD CAY, NEW PROVIDENCE C5 00000
Business Address CAY HOUSE EP TAYLOR DRIVE N7776 LYFORD CAY, NEW PROVIDENCE C5 00000 407-909-9970
Braslyn Ltd. (Reporting) CIK: 0001642355 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35921 | Film No.: 21731602